BEAM
Price
$17.82
Change
+$0.19 (+1.08%)
Updated
Aug 15 closing price
Capitalization
1.8B
85 days until earnings call
KURA
Price
$7.34
Change
+$0.74 (+11.21%)
Updated
Aug 15 closing price
Capitalization
637.09M
74 days until earnings call
Interact to see
Advertisement

BEAM vs KURA

Header iconBEAM vs KURA Comparison
Open Charts BEAM vs KURABanner chart's image
Beam Therapeutics
Price$17.82
Change+$0.19 (+1.08%)
Volume$2.15M
Capitalization1.8B
Kura Oncology
Price$7.34
Change+$0.74 (+11.21%)
Volume$4.33M
Capitalization637.09M
BEAM vs KURA Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. KURA commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and KURA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (BEAM: $17.82 vs. KURA: $7.34)
Brand notoriety: BEAM and KURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 92% vs. KURA: 306%
Market capitalization -- BEAM: $1.8B vs. KURA: $637.09M
BEAM [@Biotechnology] is valued at $1.8B. KURA’s [@Biotechnology] market capitalization is $637.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileKURA’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • KURA’s FA Score: 1 green, 4 red.
According to our system of comparison, KURA is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while KURA’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 5 bearish.
  • KURA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, KURA is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +1.14% price change this week, while KURA (@Biotechnology) price change was +32.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.90%. For the same industry, the average monthly price growth was +26.70%, and the average quarterly price growth was +20.91%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

KURA is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+9.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.8B) has a higher market cap than KURA($637M). KURA YTD gains are higher at: -15.729 vs. BEAM (-28.145). KURA has higher annual earnings (EBITDA): -177.18M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. KURA (658M). KURA has less debt than BEAM: KURA (19.4M) vs BEAM (158M). KURA has higher revenues than BEAM: KURA (68M) vs BEAM (63.6M).
BEAMKURABEAM / KURA
Capitalization1.8B637M283%
EBITDA-399.03M-177.18M225%
Gain YTD-28.145-15.729179%
P/E RatioN/AN/A-
Revenue63.6M68M94%
Total Cash1.22B658M185%
Total Debt158M19.4M814%
FUNDAMENTALS RATINGS
KURA: Fundamental Ratings
KURA
OUTLOOK RATING
1..100
87
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMKURA
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 9 days ago
84%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MDDCX26.210.06
+0.23%
BlackRock Emerging Mkts Inv A
LGCAX19.580.01
+0.05%
Lord Abbett Global Equity A
HBLFX14.94N/A
N/A
Hartford Balanced Income F
GPMCX15.90-0.05
-0.31%
Grandeur Peak Global Micro Cap Instl
FBSIX38.82-0.19
-0.49%
Franklin Mutual U.S. Mid Cap Value R6